609
Participants
Start Date
February 28, 2009
Primary Completion Date
November 30, 2009
Study Completion Date
November 30, 2009
Azilsartan medoxomil and chlorthalidone
"Azilsartan medoxomil 40 mg and chlorthalidone 12.5 mg combination tablet, orally, once daily and hydrochlorothiazide placebo-matching tablets, orally, once daily for up to 10 weeks.~For participants who do not achieve target blood pressure by Week 6, the dose of chlorthalidone will be increased for the remaining 4 weeks of treatment."
Azilsartan medoxomil and hydrochlorothiazide
"Azilsartan medoxomil 40 mg, tablets, orally, once daily and hydrochlorothiazide 12.5 mg, tablets, orally, once daily for up to 10 weeks.~For participants who do not achieve target blood pressure by Week 6, the dose of hydrochlorothiazide will be increased for the remaining 4 weeks of treatment."
Birmingham
Gulf Shores
Scottsboro
Gilbert
Sierra Vista
Paramount
Sacramento
San Diego
Colorado Springs
Wheat Ridge
Milford
Adventura
Aventura
Brooksville
Crystal River
DeLand
Doral
Miami
Naranja
Sarasota
Tampa
West Palm Beach
Winter Haven
Atlanta
Stockbridge
Suwanee
Huntsville
Bloomington
Valparaiso
Crestview Hills
Lexington
West Yarmouth
Ann Arbor
City of Saint Peters
St Louis
New Windsor
Asheboro
Cincinnati
Kettering
Downingtown
Lancaster
Lansdale
Pittsburgh
Goose Creek
Taylors
Bryan
San Antonio
Ettrick
Seattle
Madison
Moscow
Perm
Saint Petersburg
Lead Sponsor
Takeda
INDUSTRY